Role of Biofilm Formation in the Drop of Bacterial Resistance to Antibiotics after Animal Therapy with Silver Nanoparticles

Xehetasun bibliografikoak
Parent link:ACS Applied Nano Materials.— .— Washington: American Chemical Society
Vol. 7, iss. 14.— 2024.— P. 16553–16563
Erakunde egilea: National Research Tomsk Polytechnic University (570)
Beste egile batzuk: Maklakova M. Maria, Villarreal-Gomez Luis Jesus, Shkil N. N. Nikolay, Pestryakov A. N. Aleksey Nikolaevich, Bogdanchikova N. Nina
Gaia:Title screen
Bacterial biofilm formation poses significant consequences in the treatment of infections, leading to increased virulence and antibiotic resistance of bacteria and evasion of immune responses. Various methods aimed at preventing biofilm formation were investigated, including the use of silver nanoparticles (AgNPs). However, the previous studies were focused on the efficacy of AgNPs in vitro. In this study, we investigated the effectiveness of AgNPs in vivo in treating 700 cows with subclinical mastitis. The results obtained with AgNP therapy were compared with results obtained with first-line antibiotic-containing drug therapy. The biofilm formation index was quantified by using the crystal violet test. The number of isolates with strong and weak biofilm formation activities was assessed. Our findings demonstrate that therapy with AgNPs resulted in a reduction in the average index of biofilm-forming activity of six bacteria by 20.4% for strong biofilms and by 16.4% for weak biofilms across six bovine mastitis-causing pathogens (Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus dysgalactiae, Escherichia coli, Streptococcus agalactiae, and Streptococcus pyogenes). Conversely, treatment with antibiotic-containing drug led to a 40.4% increase in the average index of biofilm-forming activity for isolates with strong biofilms and an 8.7% increase for isolates with weak biofilms. Additionally, the number of strong biofilm isolates increased by an average of 232% after the antibiotic treatment. Therefore, our study identified the fourth reason for the recently revealed phenomenon of the decrease of bacterial resistance caused by animal therapy with AgNPs, highlighting as well the potential of AgNPs as a therapeutic intervention against biofilm-associated infections. This translational research represents a significant advancement from laboratory studies to real-world applications of AgNP therapy for the decrease of bacterial antibiotic resistance.
Текстовый файл
Hizkuntza:ingelesa
Argitaratua: 2024
Gaiak:
Sarrera elektronikoa:https://doi.org/10.1021/acsanm.4c02566
Formatua: Baliabide elektronikoa Liburu kapitulua
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=674320

MARC

LEADER 00000naa0a2200000 4500
001 674320
005 20240903105550.0
090 |a 674320 
100 |a 20240903d2024 k||y0engy50 ba 
101 0 |a eng 
102 |a US 
135 |a drcn ---uucaa 
181 0 |a i   |b  e  
182 0 |a b 
183 0 |a cr  |2 RDAcarrier 
200 1 |a Role of Biofilm Formation in the Drop of Bacterial Resistance to Antibiotics after Animal Therapy with Silver Nanoparticles  |f Maria Maklakova, Luis Jesus Villarreal-Gomez, Ekaterina Nefedova [et al.]  
203 |a Текст  |b визуальный  |c электронный 
283 |a online_resource  |2 RDAcarrier 
300 |a Title screen 
320 |a References: 59 tit. 
330 |a Bacterial biofilm formation poses significant consequences in the treatment of infections, leading to increased virulence and antibiotic resistance of bacteria and evasion of immune responses. Various methods aimed at preventing biofilm formation were investigated, including the use of silver nanoparticles (AgNPs). However, the previous studies were focused on the efficacy of AgNPs in vitro. In this study, we investigated the effectiveness of AgNPs in vivo in treating 700 cows with subclinical mastitis. The results obtained with AgNP therapy were compared with results obtained with first-line antibiotic-containing drug therapy. The biofilm formation index was quantified by using the crystal violet test. The number of isolates with strong and weak biofilm formation activities was assessed. Our findings demonstrate that therapy with AgNPs resulted in a reduction in the average index of biofilm-forming activity of six bacteria by 20.4% for strong biofilms and by 16.4% for weak biofilms across six bovine mastitis-causing pathogens (Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus dysgalactiae, Escherichia coli, Streptococcus agalactiae, and Streptococcus pyogenes). Conversely, treatment with antibiotic-containing drug led to a 40.4% increase in the average index of biofilm-forming activity for isolates with strong biofilms and an 8.7% increase for isolates with weak biofilms. Additionally, the number of strong biofilm isolates increased by an average of 232% after the antibiotic treatment. Therefore, our study identified the fourth reason for the recently revealed phenomenon of the decrease of bacterial resistance caused by animal therapy with AgNPs, highlighting as well the potential of AgNPs as a therapeutic intervention against biofilm-associated infections. This translational research represents a significant advancement from laboratory studies to real-world applications of AgNP therapy for the decrease of bacterial antibiotic resistance. 
336 |a Текстовый файл 
461 1 |t ACS Applied Nano Materials  |c Washington  |n American Chemical Society 
463 1 |t Vol. 7, iss. 14  |v P. 16553–16563  |d 2024 
610 1 |a труды учёных ТПУ 
610 1 |a электронный ресурс 
610 1 |a silver nanoparticles 
610 1 |a biofilm formation decrease 
610 1 |a drop of antibiotic resistance 
610 1 |a cow mastitis 
610 1 |a translational research 
701 1 |a Maklakova  |b M.  |g Maria  
701 1 |a Villarreal-Gomez  |3 L. J.  |g Luis Jesus 
701 1 |a Shkil  |b N. N.  |g Nikolay 
701 1 |a Pestryakov  |b A. N.  |c Chemist  |c Professor of Tomsk Polytechnic University, Doctor of Chemical Science  |f 1963-  |g Aleksey Nikolaevich  |9 14796 
701 1 |a Bogdanchikova  |b N.  |g Nina 
712 0 2 |a National Research Tomsk Polytechnic University  |9 27197  |4 570 
801 0 |a RU  |b 63413507  |c 20240903 
856 4 |u https://doi.org/10.1021/acsanm.4c02566  |z https://doi.org/10.1021/acsanm.4c02566 
942 |c CR